We now provide evidence in primary human 3D cultures of constitutive antineurogenic signalling via the IL1-β-IL-1R and HMGB1 RAGE/TLR4 pathways and demonstrate pharmacological reversibility in tissue from patients with severe long-standing drug refectory epilepsy and memory impairments. The gene discussed is HMGB1; the disease is epilepsy.